We are live on ! Find out more
KURA icon

Kura Oncology
KURA

66 hedge funds and large institutions have $290M invested in Kura Oncology in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 3

300% more funds holding in top 10

Funds holding in top 10: 1 → 4 (+3)

189% more capital invested

Capital invested by funds: $101M → $290M (+$190M)

150% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 10

50% more funds holding

Funds holding: 44 → 66 (+22)

19.62% more ownership

Funds ownership: 50.51% → 70.13% (+20%)

Holders
66
Holders Change
+22
Holders Change %
+50%
% of All Funds
1.65%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.1%
New
25
Increased
25
Reduced
10
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$16.4M
2
EC
EcoR1 Capital
California
+$16.3M
3
BI
BVF Inc
California
+$12.7M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.17M
5
CS
Candriam SCA
Luxembourg
+$5.07M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$5.02M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.15M
3
CCP
Clough Capital Partners
Massachusetts
-$1.84M
4
MA
Minerva Advisors
Pennsylvania
-$577K
5
OAM
Oxford Asset Management
United Kingdom
-$217K
Name Holding Trade Value Shares
Change 		Change in
Stake
IHM
26
Iguana Healthcare Management
New York
$1.35M +$845K +90,000 New
VF
27
Virtu Financial
New York
$1.03M +$644K +68,658 New
AGA
28
Altrinsic Global Advisors
Connecticut
$897K +$563K +60,000 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$886K +$263K +28,031 +90%
JP Morgan Chase
30
JP Morgan Chase
New York
$802K +$521K +55,471 New
TCIM
31
TIAA CREF Investment Management
New York
$697K +$49.3K +5,248 +13%
NFA
32
Nationwide Fund Advisors
Ohio
$643K +$162K +17,223 +67%
Charles Schwab
33
Charles Schwab
California
$587K +$140K +14,900 +61%
Morgan Stanley
34
Morgan Stanley
New York
$565K -$5.02M -534,467 -93%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$471K +$58.2K +6,200 +25%
PPCM
36
Pillar Pacific Capital Management
California
$456K – – –
JMPWA
37
JP Morgan Private Wealth Advisors
California
$441K – – –
PIM
38
Partner Investment Management
California
$384K +$27.4K +2,921 +13%
TA
39
Teachers Advisors
New York
$371K -$25.2K -2,689 -10%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$351K – – –
Goldman Sachs
41
Goldman Sachs
New York
$293K +$184K +19,632 New
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$259K +$18.8K +2,000 +13%
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$249K +$147K +15,698 +1,677%
UBS Group
44
UBS Group
Switzerland
$227K +$143K +15,204 New
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$222K +$7K +746 +5%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$218K +$137K +14,568 New
EMG
47
Ellington Management Group
Connecticut
$212K +$133K +14,200 New
CS
48
Credit Suisse
Switzerland
$190K +$120K +12,761 New
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$164K – – –
Parallax Volatility Advisers
50
Parallax Volatility Advisers
California
$150K +$93.9K +10,000 New
1
2
3

KURA Hedge Fund Activity: Q3 2017 in Review

66 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2017, worth a combined $290M — up 189% from $101M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new KURA positions and 3 closed out — a net gain of 22 holders — while 25 added to existing stakes and 10 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $16.4M. The largest seller was Morgan Stanley, cutting an estimated $5.02M.

  • 66 institutional investors held Kura Oncology (KURA) as of Q3 2017, up from 44 in Q2 2017.
  • Funds reported $290M of Kura Oncology stock for Q3 2017, up 189% quarter-over-quarter.
  • 25 funds opened new Kura Oncology positions in Q3 2017 and 3 closed out, a net change of +22 holders.
  • The largest Kura Oncology buyer in Q3 2017 was Great Point Partners, an estimated $16.4M added.
  • The largest Kura Oncology seller in Q3 2017 was Morgan Stanley, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2017.